AMRS Amyris, Inc. Stock Quote

publish chart | save to portfolio | create alert

AMRS [NASD]

Amyris, Inc.

Basic Materials | Specialty Chemicals | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.87	Insider Own	0.60%	Shs Outstand	227.27M	Perf Week	28.63%
Market Cap	688.89M	Forward P/E	-	EPS next Y	-0.37	Insider Trans	260.63%	Shs Float	159.68M	Perf Month	8.55%
Income	-350.90M	PEG	-	EPS next Q	-0.09	Inst Own	43.90%	Short Float	15.09%	Perf Quarter	-13.61%
Sales	133.90M	P/S	5.14	EPS this Y	27.80%	Inst Trans	34.93%	Short Ratio	7.78	Perf Half Y	-45.42%
Book/sh	-0.39	P/B	-	EPS next Y	72.90%	ROA	-179.60%	Target Price	-	Perf Year	-27.00%
Cash/sh	0.16	P/C	17.99	EPS next 5Y	30.00%	ROE	242.80%	52W Range	1.40 - 6.07	Perf YTD	-5.50%
Dividend	-	P/FCF	-	EPS past 5Y	-51.90%	ROI	-	52W High	-51.89%	Beta	0.79
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	28.70%	Gross Margin	37.70%	52W Low	108.57%	ATR	0.23
Employees	561	Current Ratio	1.30	Sales Q/Q	-2.00%	Oper. Margin	-	RSI (14)	63.12	Volatility	10.26% 9.71%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	34.40%	Profit Margin	-	Rel Volume	0.75	Prev Close	2.88
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 05 BMO	Payout	-	Avg Volume	3.10M	Price	2.92
Recom	1.70	SMA20	23.49%	SMA50	8.53%	SMA200	-9.35%	Volume	2,296,240	Change	1.39%

Nov-25-20

Initiated

Jefferies

Buy

$3.35

Nov-25-20

Initiated

Cowen

Market Perform

Dec-12-19

Initiated

Oppenheimer

Outperform

Nov-14-18

Reiterated

B. Riley FBR

Buy

$10 → $8

Jan-25-18

Initiated

B. Riley FBR, Inc.

Buy

May-28-14

Resumed

Stifel

Hold

Feb-10-12

Downgrade

Deutsche Bank

Buy → Hold

$20 → $9

Nov-02-11

Downgrade

Robert W. Baird

Outperform → Neutral

$25 → $16

Jan-28-11

Downgrade

Stifel Nicolaus

Buy → Hold

Nov-08-10

Initiated

Stifel Nicolaus

Buy

$22

Nov-24-20 03:42PM	Top Marijuana Stocks on the NASDAQ for December 2020 Investopedia +8.26%
Nov-23-20 08:00AM	Amyris To Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 3, 2020 PR Newswire +5.22%
Nov-18-20 10:23AM	New Strong Sell Stocks for November 18th Zacks
Nov-05-20 08:00AM	Amyris, Inc. Reports Third Quarter 2020 Financial Results PR Newswire -19.01%
Oct-30-20 08:00AM	Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership PR Newswire -5.66%
Oct-26-20 11:00AM	INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors Business Wire -6.23%
Oct-23-20 07:06PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors Business Wire +7.02%
08:00AM	Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5 PR Newswire
Oct-22-20 08:00AM	Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine PR Newswire
Oct-20-20 09:30AM	Amyris and Arzeda Enter into Development Collaboration Agreement PR Newswire
Oct-09-20 09:00AM	Kaskela Law LLC Announces Stockholder Investigation of Amyris, Inc. (AMRS) and Encourages Long-Term Investors to Contact the Firm PR Newswire
Oct-08-20 09:00AM	The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors Business Wire
Oct-07-20 09:22AM	Why Amyris Fell 11% in September Motley Fool
Oct-01-20 08:30AM	Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed PR Newswire +6.51%
Sep-22-20 07:00PM	Media Advisory - Canfor Corporation and Canfor Pulp Products Inc. Announce Third Quarter Results Conference Call CNW Group
Sep-21-20 08:30AM	Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales PR Newswire
Sep-15-20 08:30AM	Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada PR Newswire +8.26%
Sep-14-20 07:00AM	Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today PR Newswire
Sep-11-20 04:22PM	Why Amyris Shares Dropped 26% Today Motley Fool -25.80%
03:25PM	Amyris Denies 'Patent Infringement' Allegations On Heels Of $881M Lavvan Lawsuit Benzinga
05:00AM	Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020 PR Newswire
Sep-10-20 03:41PM	LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation PR Newswire
Sep-08-20 08:30AM	Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 PR Newswire
Sep-04-20 08:50AM	New Strong Sell Stocks for September 4th Zacks -6.44%
Sep-01-20 03:30PM	Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential TipRanks
08:30AM	Amyris Scales First Fermentation-Based Cannabinoid PR Newswire
08:30AM	Amyris Scales First Fermentation-Based Cannabinoid CNW Group
Aug-20-20 08:31AM	Should Amyris Split Into 2 Companies? Motley Fool
Aug-14-20 08:30AM	Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance PR Newswire -5.50%
Aug-06-20 08:30AM	Amyris, Inc. Reports Second Quarter 2020 Results PR Newswire -18.32%
Jul-30-20 03:21PM	Top Marijuana Stocks for August 2020 Investopedia
Jul-29-20 05:01PM	Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc. GlobeNewswire
12:25PM	INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS PR Newswire
Jul-28-20 09:07PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc. PR Newswire
Jul-27-20 12:41PM	Here's Why Amyris Stock Rose as Much as 12.2% Today Motley Fool +6.57%
08:30AM	Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application PR Newswire
Jul-23-20 08:30AM	Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6 PR Newswire
Jul-20-20 01:29PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:20PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
09:53AM	INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS) ACCESSWIRE
Jul-18-20 11:16AM	INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS) ACCESSWIRE
Jul-17-20 12:40PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Jul-16-20 07:25PM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:31PM	INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-15-20 03:40PM	INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ: AMRS) ACCESSWIRE -6.35%
08:30AM	Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications PR Newswire
Jul-09-20 10:00AM	INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Amyris, Inc. for Potential Breach of Fiduciary Duty Claims ACCESSWIRE -5.63%
Jul-02-20 10:39PM	Implied Volatility Surging for Amyris (AMRS) Stock Options Zacks +5.52%
Jun-30-20 08:30AM	Biossance Announces Clean Academy Impact Award and Partnership With Oceana PR Newswire
Jun-29-20 12:00PM	Low-Priced Amyris Could Surprise on the Upside TheStreet.com
Jun-22-20 08:30AM	Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE Sweetener PR Newswire +12.50%
Jun-10-20 08:30AM	Amyris Announces Closing Of $200 Million Private Placement PR Newswire -6.37%
Jun-04-20 08:58AM	Amyris Raises $200 Million From Private Placement PR Newswire
Jun-02-20 08:37AM	Edited Transcript of AMRS earnings conference call or presentation 8-May-20 1:00pm GMT Thomson Reuters StreetEvents -9.16%
Jun-01-20 05:31PM	Stock Market Wrap-Up: Why These 2 Under-the-Radar Stocks Jumped Monday Motley Fool +43.43%
12:29PM	Here's Why Amyris Is Soaring Today Motley Fool
12:00PM	This Could Be the Next Big Pot Stock Motley Fool
May-27-20 01:33PM	Penny Stocks to Watch for June 2020 Investopedia -5.62%
May-21-20 09:18AM	Amyris Launches Safe Alternative To Talc-Based Baby Powder PR Newswire
May-17-20 08:00PM	Is Another Accounting Issue Brewing for Amyris? Motley Fool
May-15-20 08:30AM	Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format PR Newswire +9.24%
May-14-20 09:36AM	Is Amyris Finally Turning a Corner? Motley Fool
08:30AM	Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient PR Newswire
May-08-20 08:30AM	Amyris, Inc. Reports First Quarter 2020 Results PR Newswire +6.35%
May-07-20 08:30AM	Amyris to Participate in the Oppenheimer 5th Annual Emerging Growth Conference on May 12 PR Newswire +7.69%
May-04-20 08:30AM	Amyris To Host First Quarter 2020 Financial Results Conference Call On May 8 PR Newswire
Apr-21-20 07:10PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amyris, Inc.- AMRS ACCESSWIRE
Apr-20-20 08:30AM	Amyris Receives Approval to Sell its Fermented Sugarcane Reb M in Brazil and Canada PR Newswire
Apr-13-20 07:30AM	Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family PR Newswire -5.67%
Mar-31-20 08:30AM	Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products PR Newswire
Mar-26-20 08:30AM	Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant PR Newswire +8.96%
Mar-24-20 10:01PM	Edited Transcript of AMRS earnings conference call or presentation 12-Mar-20 8:30pm GMT Thomson Reuters StreetEvents +10.82%
Mar-23-20 06:13AM	Should You Worry About Amyris, Inc.'s (NASDAQ:AMRS) CEO Pay Cheque? Simply Wall St. -13.00%
Mar-16-20 08:05AM	Amyris Provides Business Update PR Newswire -14.67%
Mar-12-20 04:15PM	Amyris Reports Another Strong Quarter of Recurring Revenue Growth PR Newswire -10.14%
02:30PM	Amyris, Inc. to Host Earnings Call ACCESSWIRE
Mar-10-20 08:30AM	Amyris to Participate in Fireside Chat at 32nd Annual Roth Conference on March 16, 2020 PR Newswire
Mar-09-20 08:30AM	Amyris Expands Distribution of PURECANE Baking Sweetener on Amazon Strong Early Sales PR Newswire -15.00%
Mar-06-20 08:30AM	Amyris Discovers Major Breakthrough in CBD Delivery PR Newswire
Mar-05-20 08:00AM	Amyris to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Thursday, March 12 PR Newswire
Mar-03-20 08:30AM	Amyris Introduces New PURECANE Baking Sweetener Direct to Consumers on Purecane.com to Outperform Low-Calorie Competitors PR Newswire -5.19%
Feb-26-20 08:30AM	Amyris to Present at Cowen 40th Annual Health Care Conference on March 3, 2020 PR Newswire
Feb-25-20 08:30AM	Amyris Expands Distribution of PURECANE Packets on Amazon PR Newswire
Feb-23-20 05:23PM	Largest Insider Trades of the Week GuruFocus.com
Feb-19-20 08:30AM	Amyris Provides Clean Beauty Business Update PR Newswire
Feb-14-20 08:30AM	Biossance Expands The Clean Academy The Ultimate Clean Beauty Resource PR Newswire
Feb-13-20 08:30AM	Amyris, Inc. Appoints Han Kieftenbeld As Chief Financial Officer PR Newswire
Feb-07-20 05:29AM	Insider Buying: The Amyris, Inc. (NASDAQ:AMRS) Independent Director Just Bought US$30m Worth Of Shares Simply Wall St. +5.40%
Feb-03-20 09:05AM	Amyris Announces Execution of Definitive Agreements for up to an Anticipated $70 Million Debt Reduction Via Exercise of Existing Warrants and $42 Million in New Financing PR Newswire +11.72%
Jan-23-20 08:30AM	Clean Beauty Leader Biossance Lands in the UK PR Newswire
Jan-15-20 05:10AM	How Does Amyris, Inc. (NASDAQ:AMRS) Affect Your Portfolio Volatility? Simply Wall St.
Jan-13-20 08:44AM	Options Traders Expect Huge Moves in Amyris (AMRS) Stock Zacks
08:30AM	Amyris Provides Update - Achieves Record Fourth-Quarter 2019 Product Shipments; Clean Beauty Produces Breakout Performance PR Newswire
Dec-27-19 08:30AM	Amyris Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates PR Newswire
Dec-19-19 03:51PM	Were Hedge Funds Right Dumping Amyris Inc (AMRS)? Insider Monkey
Dec-17-19 08:30AM	WWD Beauty Inc Names Biossance Brand Digital Innovator Of The Year PR Newswire
Dec-13-19 08:50AM	Options Traders Expect Huge Moves in Amyris (AMRS) Stock Zacks -6.72%
Dec-12-19 04:52PM	SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Continues Investigating Amyris, Inc.'s Directors and Officers for Breach of Fiduciary Duty - AMRS PR Newswire +7.87%
Dec-10-19 06:05AM	How Many Amyris, Inc. (NASDAQ:AMRS) Shares Did Insiders Buy, In The Last Year? Simply Wall St. +6.03%
Dec-04-19 08:30AM	Biossance Leading the Clean Beauty Revolution with Biossance.com Cyber Monday Sales up over 3X from Last Year, Marking Highest One-Day Sales in Brand History PR Newswire -7.36%

Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company's technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies technology platform to engineer, manufacture, and sell products for the clean health and beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kung Frank	Director	Jun 05	Buy	3.00	3,689,225	11,067,675	6,284,876	Jun 09 09:06 PM
DOERR L JOHN	Director	Mar 11	Option Exercise	2.87	5,226,481	15,000,000	58,490,128	Mar 13 08:26 PM
DOERR L JOHN	Director	Feb 19	Buy	3.41	52,785	179,997	53,263,647	Feb 21 07:34 PM
Melo John	President and CEO	Feb 19	Sale	3.41	52,875	180,304	642,097	Feb 21 07:33 PM
DOERR L JOHN	Director	Jan 31	Option Exercise	2.84	19,287,780	54,767,092	42,705,210	Feb 04 08:16 PM
DOERR L JOHN	Director	Jan 31	Buy	2.87	10,505,652	30,151,221	53,210,862	Feb 04 08:16 PM
DOERR L JOHN	Director	Jan 13	Option Exercise	2.87	4,877,386	13,998,098	23,417,430	Jan 15 08:46 PM
Yang Patrick Y	Director	Dec 10	Sale	3.10	10,671	33,080	43,527	Dec 12 08:37 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience